Next Article in Journal
Culture-Independent Study of the Late-Stage of a Bloom of the Toxic Dinoflagellate Ostreopsis cf. ovata: Preliminary Findings Suggest Genetic Differences at the Sub-Species Level and Allow ITS2 Structure Characterization
Previous Article in Journal
Onabotulinumtoxin A Treatment of Drooling in Children with Cerebral Palsy: A Prospective, Longitudinal Open-Label Study
Previous Article in Special Issue
Development of Plate Reader and On-Line Microfluidic Screening to Identify Ligands of the 5-Hydroxytryptamine Binding Protein in Venoms
Open AccessArticle

Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula

The University of Queensland, Institute for Molecular Bioscience, St Lucia, Queensland 4072, Australia
*
Authors to whom correspondence should be addressed.
Academic Editor: Jean-Marc Sabatier
Toxins 2015, 7(7), 2494-2513; https://doi.org/10.3390/toxins7072494
Received: 15 April 2015 / Revised: 19 June 2015 / Accepted: 24 June 2015 / Published: 30 June 2015
(This article belongs to the Special Issue Selected Papers from the 5th Venoms to Drugs Meeting)
Voltage-gated sodium (NaV) channels are responsible for propagating action potentials in excitable cells. NaV1.7 plays a crucial role in the human pain signalling pathway and it is an important therapeutic target for treatment of chronic pain. Numerous spider venom peptides have been shown to modulate the activity of NaV channels and these peptides represent a rich source of research tools and therapeutic lead molecules. The aim of this study was to determine the diversity of NaV1.7-active peptides in the venom of an Australian Phlogius sp. tarantula and to characterise their potency and subtype selectivity. We isolated three novel peptides, μ-TRTX-Phlo1a, -Phlo1b and -Phlo2a, that inhibit human NaV1.7 (hNaV1.7). Phlo1a and Phlo1b are 35-residue peptides that differ by one amino acid and belong in NaSpTx family 2. The partial sequence of Phlo2a revealed extensive similarity with ProTx-II from NaSpTx family 3. Phlo1a and Phlo1b inhibit hNaV1.7 with IC50 values of 459 and 360 nM, respectively, with only minor inhibitory activity on rat NaV1.2 and hNaV1.5. Although similarly potent at hNaV1.7 (IC50 333 nM), Phlo2a was less selective, as it also potently inhibited rNaV1.2 and hNaV1.5. All three peptides cause a depolarising shift in the voltage-dependence of hNaV1.7 activation. View Full-Text
Keywords: Phlogius sp.; spider venom; venom peptide; voltage-gated sodium channel; NaV1.7; two-electrode voltage clamp electrophysiology; ion channel; mass spectrometry Phlogius sp.; spider venom; venom peptide; voltage-gated sodium channel; NaV1.7; two-electrode voltage clamp electrophysiology; ion channel; mass spectrometry
Show Figures

Graphical abstract

MDPI and ACS Style

Chow, C.Y.; Cristofori-Armstrong, B.; Undheim, E.A.B.; King, G.F.; Rash, L.D. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula. Toxins 2015, 7, 2494-2513. https://doi.org/10.3390/toxins7072494

AMA Style

Chow CY, Cristofori-Armstrong B, Undheim EAB, King GF, Rash LD. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula. Toxins. 2015; 7(7):2494-2513. https://doi.org/10.3390/toxins7072494

Chicago/Turabian Style

Chow, Chun Y.; Cristofori-Armstrong, Ben; Undheim, Eivind A.B.; King, Glenn F.; Rash, Lachlan D. 2015. "Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula" Toxins 7, no. 7: 2494-2513. https://doi.org/10.3390/toxins7072494

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop